Peptides & Peptide Synthesis Products

Fmoc-Lys-OH

Fmoc-Lys-OH

$25.00
$25.00
Fmoc-Lys-OH, Catalog No: 41079
(2S)-6-amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid, CAS: 105047-45-8, MW: 368.43, Formula: C21H24N2O4
Catalog No: 41079
(2S)-6-amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid, CAS: 105047-45-8, MW: 368.43, Formula: C21H24N2O4
Description

Details

(2S)-6-amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid
Additional Information

Additional Information

Catalog Number 41079
CAS 105047-45-8
M.W. 368.43
Formula C21H24N2O4
IUPAC Name (2S)-6-amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid
Synonym No
Also Known As
  • (2S)-6-amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid
  • (2S)-6-amino-2-[(9H-fluoren-9-ylmethoxy-oxomethyl)amino]hexanoic acid
  • 17290_FLUKA
  • Fmoc-Lys-OH hydrochloride
  • Nalpha-Fmoc-L-lysine hydrochloride
  • (2S)-6-azaniumyl-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoate
  • (2S)-6-ammonio-2-[(9H-fluoren-9-ylmethoxy-oxomethyl)amino]hexanoate
  • (2S)-6-ammonio-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoate
  • ZINC02391045
InChIKey YRKFMPDOFHQWPI-IBGZPJMESA-N
InChI InChI=1S/C21H24N2O4/c22-12-6-5-11-19(20(24)25)23-21(26)27-13-18-16-9-3-1-7-14(16)15-8-2-4-10-17(15)18/h1-4,7-10,18-19H,5-6,11-13,22H2,(H,23,26)(H,24,25)/t19-/m0/s1
SMILES C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)N[C@@H](CCCCN)C(=O)O
Cited Uses

Details

1. Banerjee SR et al, "Effect of Chelators on the Pharmacokinetics of 99mTc-Labeled Imaging Agents for the Prostate-Specific Membrane Antigen (PSMA)", Journal of medicinal chemistry, 56(15) pp.6108-6121 (2013 Aug 8).
2. Bionda N et al, "Effects of cyclic lipodepsipeptide structural modulation on stability, antibacterial activity and human cell toxicity", ChemMedChem, 7(5) pp.871-882 (2012 May).
3. Kawamoto SA et al, "Design of Triazole-stapled BCL9 ?-Helical Peptides to Target the ?-Catenin/B-cell CLL/lymphoma 9 (BCL9) Protein-Protein Interaction", Journal of Medicinal Chemistry, 55(3) pp.1137-1146 (2012 Feb 9).
4. Madden MM et al, "Synthesis of Cell-Permeable Stapled Peptide Dual Inhibitors of the p53-Mdm2/Mdmx Interactions via Photoinduced Cycloaddition", Bioorganic & medicinal chemistry letters, 21(5) pp.1472-1475 (2011 Mar 1).
5. Fields GB et al, "Synthesis and biological applications of collagen-model triple-helical peptides", Organic & biomolecular chemistry, 8(6) pp.1237-1258 (2010 Mar 21).
6. Baumhover NJ et al, "Synthesis and In Vitro Testing of New Potent Polyacridine-Melittin Gene Delivery Peptides", Bioconjugate chemistry, 21(1) pp.74 (2010 Jan).
7. Lu L et al, "Synthesis and Structural Characterization of Carboxyethylpyrrole-Modified Proteins: Mediators of Age-related Macular Degeneration", Bioorganic & medicinal chemistry, 17(21) pp.7548-7561 (2009 Nov 1).
8. Zhang L et al, "Structural Requirements for a Lipoamino Acid in Modulating the Anticonvulsant Activities of the Systemically-Active Galanin Analogs", Journal of medicinal chemistry, 52(5) pp.1310-1316 (2009 Mar 12).
9. Szewczuk LM et al, "Mechanistic Analysis of a Suicide Inactivator of Histone Demethylase LSD1", Biochemistry, 46(23) pp.6892-6902 (2007 Jun 12).
Reviews
cr